title: Minor histocompatibility antigens: presentation principles, recognition logic and the potential for a healing hand.
abstract: OBJECTIVE
  There is ample evidence indicating a pathologic role for minor histocompatibility antigens in inciting graft-versus-host disease in major histocompatibility complex (MHC)-matched bone marrow transplantation and rejection of solid organ allografts. Here we review the current knowledge of the genetic and biochemical bases for the cause of minor histoincompatibility and the structural basis for the recognition of the resulting alloantigens by the T-cell receptor.
  
  
  RESULTS
  Recent evidence indicates that we as independently conceived individuals are genetically unique, thus, offering a mechanism for minor histoincompatibility between MHC-identical donor-recipient pairs. Furthermore, advances in delineating the mechanisms underlying antigen cross-presentation by MHC class I molecules and a critical role for autophagy in presenting cytoplasmic antigens by MHC class II molecules have been made. These new insights coupled with the X-ray crystallographic solution of several peptide/MHC-T-cell receptor structures have revealed mechanisms of histoincompatibility.
  
  
  CONCLUSIONS
  On the basis of these new insights, ways to test for allograft compatibility and concoction of immunotherapies are discussed.
authors.affiliation: Department of Microbiology and Immunology, Vanderbilt University School of Medicine, 116121st Avenue South, Nashville, TN 37232, USA.
authors.forename: Charles T
authors.initials: CT
authors.lastname: Spencer
authors.forename: Pavlo
authors.initials: P
authors.lastname: Gilchuk
authors.forename: Srdjan M
authors.initials: SM
authors.lastname: Dragovic
authors.forename: Sebastian
authors.initials: S
authors.lastname: Joyce
mesh_terms: D000818:Animals; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control; D006085:Graft Survival; D006086:Graft vs Host Disease / Q000276:immunology* / Q000517:prevention & control; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007249:Inflammation / Q000276:immunology; D007519:Isoantigens / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D008024:Ligands; D015778:Minor Histocompatibility Antigens / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D008958:Models, Molecular; D011487:Protein Conformation; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*; D013329:Structure-Activity Relationship; D013601:T-Lymphocytes / Q000276:immunology*; D023001:Transplantation Tolerance; D014184:Transplantation, Homologous
chemical_list: D007519:Isoantigens; D008024:Ligands; D015778:Minor Histocompatibility Antigens; D011948:Receptors, Antigen, T-Cell